Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Biomarkers in Immunotherapy of Melanoma [NA]
A clinical trial update on biomarker research for immunotherapy in metastatic melanoma, including analyses of the gastrointestinal microbiom…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy [NA]
A clinical trial update noting recruitment for a study evaluating telemonitoring to manage side effects in patients with melanoma, lung canc…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma [NA]
A completed preclinical study using tumor replicates in an avian embryo to model the effects of BRAF inhibitors and MEK inhibitors in BRAF-m…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
This clinical trial update describes a study evaluating skin health and quality of life in patients receiving anti-PD-1/PD-L1/CTLA-4 inhibit…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 evaluation of NGM707 as a monotherapy and in combination with pembrolizumab in advanc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults
This clinical trial update describes an AI-based approach for early diagnosis and risk prediction of melanoma in children, adolescents, and …
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Study to Examine Lesions of the Skin Using Confocal Laser Microscopy
This document details an active, non-recruiting clinical trial sponsored by LMU Klinikum that uses confocal laser microscopy to examine skin…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma
This clinical trial investigates gene expression profiles and circulating tumor DNA (ctDNA) to stratify risk in melanoma patients. The study…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors [Phase 1, Phase 2]
A Phase 1b/2a trial evaluating ENB003 in combination with pembrolizumab for various solid tumors, including melanoma, ovarian cancer, pancre…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)
This clinical trial update indicates ongoing recruitment for a neoadjuvant immunotherapy study in operable metastatic melanoma conducted at …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: MELCAYA - Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults - Work Package 3 (WP3)
Clinical trial update for MELCAYA WP3 studying novel health care strategies for melanoma in children, adolescents, and young adults; current…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease [Phase 2]
Phase 2 clinical trial exploring immunotherapy combined with carbon ion radiotherapy in solid cancers with stable disease, currently recruit…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors [Phase 1]
RemeGen's RC198 is being evaluated in a Phase 1 study across locally advanced unresectable or metastatic solid tumors, including melanoma, u…
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma [NA]
A single-arm multicenter clinical trial evaluating the combination of Fruquintinib, Cadonilimab, and Temozolomide in second-line and later a…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma [Phase 2]
Clinical trial update for a Phase 2 study evaluating fecal microbiota transplantation in metastatic non-small cell lung cancer and advanced …
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies [Phase 2]
Phase 2 trial update for Zirconium-89 labeled Crefmirlimab Berdoxam PET/CT in advanced or metastatic cancers; the study is currently active …
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. [Phase 1]
Phase 1 trial update for YE-NEO-001, NantBioScience's personalized neoepitope yeast vaccine, evaluating adjuvant immunotherapy to elicit T-c…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors [Phase 2]
Clinical trial update describing a Phase 2 study of TQB2916 injection in combination with chemotherapy or Penpulimab for solid tumors, inclu…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma [Phase 3]
A Phase 3 trial is recruiting to compare tunlametinib capsules with combination chemotherapy in adults with advanced NRAS-mutant melanoma.
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy
This trial evaluates whole-body dynamic PET/CT imaging with FDG to assess metastatic melanoma in patients undergoing immunotherapy.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: LATe TreatmENT Related Toxicity in Melanoma (LATENT)
Clinical trial update for LATe TreatmENT Related Toxicity in Melanoma (LATENT) sponsored by Royal Marsden NHS Foundation Trust. The study fo…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors [Phase 2, Phase 3]
Clinical trial update for a Phase 2/Phase 3 study examining trans-arterial/intra-tumor infusion of checkpoint inhibitors plus chemotherapy f…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy [Phase 2]
Phase 2 trial evaluating circulating tumor DNA–guided adaptive therapy using BRAF and MEK inhibitors for melanoma; status is not yet recruit…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma
A completed clinical trial focusing on establishing and standardizing a platform for in-depth tumor profiling in patients with melanoma.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Dermoscopy Augmented Histology Trial, Consensus Agreement Diagnosis Made by Dermatopathology Experts
This ClinicalTrials.gov entry describes an ongoing study evaluating Dermoscopy Augmented Histology to support consensus diagnoses by dermato…